The report highlights a fundamental flaw in the process, given the states and territories can and do make budget-driven decisions to prevent the administration of CAR-T and gene therapies funded through the National Health Reform Agreement.
Report highlights the need for change on NHRA-funded therapies
May 9, 2023 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Montu pushes for national standards at Productivity Commission inquiry
June 17, 2025 - - Latest News -
Canadian appointed to lead New Zealand's Pharmac
June 17, 2025 - - Latest News -
US FDA approves CSL's treatment for hereditary angioedema
June 17, 2025 - - Latest News -
Australia's system is more uniform than the US, but not uniformly better
June 17, 2025 - - Latest News -
Australian company secures FDA approval to progress development of CAR-T therapy
June 16, 2025 - - Latest News -
These systems are and always have been more similar than most realise
June 16, 2025 - - Latest News -
Confirmation the UK has agreed to review medicine prices in response to US demand
June 16, 2025 - - Latest News